2013 cancer program annual report reflecting 2012 data · 2018. 1. 26. · reflecting 2012 data....
TRANSCRIPT
2013 Cancer Program Annual ReportReflecting 2012 Data
Comprehensive Cancer Center
Mount Sinai Medical Center’s Comprehensive Cancer Center takes a collaborative,
multidisciplinary approach to diagnosing and treating cancer. The award-winning cancer
treatment program cares for the whole person – body, mind and spirit. Medical oncologists,
radiation oncologists, surgical oncologists, pathologists and radiologists work together with
a support team of psychologists, social workers, pain specialists, nutritionists, rehab staff
and others to create customized treatment plans. They meet weekly at disease specific as
well a general cancer conferences to review complex cases, discuss innovative treatment
options and coordinate care across specialties using the guidelines established by the
leading cancer organizations including the National Comprehensive Cancer Network (NCCN),
American Society of Clinical Oncology (ASCO) and American Society for Therapeutic
Radiation and Oncology (ASTRO) to name a few. As an Academic Comprehensive Cancer
Program (ACSD) as designated by the Commission Cancer, our doctors are at the forefront
of medical research and lead clinical trials.
National Cancer Institute Clinical Trials: The prestigious, grant-funded Community
Clinical Oncology Program (CCOP) – created by the National Cancer Institute (NCI) –
is a nonprofit, community-based program that provides clinical research to cancer
treatment patients and those who may be at risk. The program allows Mount Sinai
patients to participate in promising clinical trials offering cutting-edge treatment
options before they become widely available to the general public.
o There are currently over 60 open cancer clinical trials available that cover a
variety of malignancies, MSMC patients have access to new drugs not yet
available in other centers.
Mount Sinai is the first Hospital in Florida to acquire and house the Evident
Microwave Ablation System to destroy tumors of the liver, kidney, lung, and to treat
other forms of soft-tissue cancers.
Consecutive winner of the “Outstanding Achievement Award” from the Commission
on Cancer (CoC) of the American College of Surgeons for three cycles (2005, 2008 &
2011) the only hospital in the State of Florida to have achieved this level of
excellence.
Mount Sinai Medical Center’s Comprehensive Breast Center was the first center in
Florida to be accredited by the National Accreditation Program for Breast Centers
(NAPBC), devoting itself to early detection, diagnosis, treatment, support and follow-
up care.
The Cancer Committee at Mount Sinai Medical Center (MSMC) is comprised of a group of
cancer professionals. This multidisciplinary administrative and clinical group includes
members from different disciplines in cancer care: physicians representing all aspects of
oncology, radiology, pathology, palliative care, dermatology and other specialties; allied
health professionals involved in diagnosis, treatment, follow-up care and family support for
cancer patients; and hospital administration. The Cancer Committee monitors all activities
related to treatment, education, research and outreach that support a quality cancer
program for our community. They work in conjunction with the Cancer Program to deliver
compassionate and high-quality care to patients, rendered at state-of-the-art facilities, and
enhanced by investigational protocols and treatments. The committee operates in
compliance with the requirements for accreditation from the American College of Surgeons
Commission on Cancer and our commitment to continued quality improvement programs
and patient centered care.
Cancer Committee Members:
Juan Paramo, MD Chair, Department of Surgical Oncology
Elisa Krill-Jackson, MD Vice Chair, Department of Medical Oncology
Robert Goldszer, MD Chief Medical Officer, Administration
Stuart Kaplan, MD Breast Leadership Program, Breast Center, Radiology
Brian Katz, MD Department of Dermatology
Nicholas Kuritzky, MD Department of Radiation Oncology, Chairman
Todd Lasner, MD Department of Neurosurgery
Jose Lutzky, MD Department of Medical Oncology, Melanoma Program
Thomas Mesko, MD Department of Surgical Oncology, Chairman
H Michael Moyses, MD Department of Radiation Oncology
Robert Poppiti, MD Department of Pathology, Chairman
Estelamari Rodriguez, MD Department of Medical Oncology, Lung Cancer Program
Barry Shipman, DMD Prosthetics & Maxillofacial Reconstruction
Henry Wodnicki, MD Department of Surgery
Robert Alonso Director, Marketing
Julia Becker, RHIA Director, HIM
Debbie Belcher Manager, Breast Center
Guerna Blot, RN Manager, Inpatient Oncology Unit
Gail Brown, LCSW Social Services
Florence Buenconsejo, ARNP Clinical Operations Director, Cancer Center
Carlos Bitar Executive Director, Cancer Center
Lisa Gonzalez-Alpizar, PhD Oncology Support Care
Craig McCollough, PhrmD Clinical Manager, Cancer Center Pharmacy
Dharma Mirabent Director, Rehab Services
Yvonne Nuñez, BSHA Manager, Community Clinical Oncology Program
Joanna Palmer Manger, Public Relations
Berta Rios, PhD American Cancer Society
Ana L Ruiz, CTR Manager, Cancer Registry
Sandy Sotnick, MSRD Nutritional Services
Breast Center
The Lila and Harold Menowitz Comprehensive Breast Center has been designated as a
Breast Imaging Center of Excellence by the American College of Radiology, and is the first
accredited National Accreditation Program for Breast Centers (NAPBC) in the state of
Florida.
Interpretations are made by a board certified and fellowship trained radiologist specializing
in mammography. In addition, each mammogram and Magnetic Resonance Imaging (MRI)
are evaluated with Computer Assisted Detection (CAD), which can identify additional areas
that may need further evaluation.
At the Comprehensive Breast Center, digital mammograms are performed by highly trained,
mammography certified radiologic technologists who are sensitive to their patients’ needs
for comfort and privacy.
Our digital mammography, ultrasound, MRI and biopsy equipment is designed specifically
for maximizing excellence in breast imaging and diagnosis.
Patients have the opportunity to discuss the results of their diagnostic mammograms with
the radiologist during their visit. Both the patient and the referring physician receive timely
reports and test results.
Our Patient Navigator is responsible for maintaining contact and tracking all patients with
abnormal screening mammograms and assisting those patients in relieving concrete and
emotional barriers to care. Responsibilities of the Patient Navigator include ensuring all
patients receive the recommended care/treatment in a timely manner, facilitate all patient
procedure appointments, provide psycho-educational material on the importance of a good
breast health plan, and provide additional support to patients who are breast cancer
survivors during their diagnostic appointments. All patients upon learning of a breast cancer
diagnosis, are contacted by, or scheduled to meet with, the Patient Navigator and provided
related literature/brochures on their diagnosis and treatment, as well as an opportunity to
discuss their diagnosis.
2013 Stats:
Digital Screening Mammography 7,716
Digital Diagnostic mammography 7,701
Breast Ultrasound 8,001
Breast MRI 454
Procedures 1,479
(including FNA, Ultrasound Guided Core Biopsy, Stereotactic Guided Core Biopsy, MRI
Guided Core Biopsy, Cyst Aspiration, Galactogram, Breast Needle Localization, and Sentinel
Node Injection)
Total annual procedures 25,351
Oncology Supportive Care
At Mount Sinai Comprehensive Cancer Center we are dedicated to a patient centered care.
The Oncology Supportive Care Department is comprised of highly skilled, multi-disciplinary
team members that include Clinical Licensed Social Workers, Psychologists, and
Nutritionists. We provide both individual and group therapy addressing the emotional needs
of our patient’s ranging from coping with the initial diagnosis, adapting and adjusting to
treatment, to processing end of life issues. Our team addresses emotional, social, and
nutritional needs while balancing the wishes of our patients to preserve quality of life. The
Oncology Supportive Care professionals are an integral part of oncology care provided at
Mount Sinai.
Every area of the cancer center has a dedicated Licensed Clinical Social Worker / Patient
Navigator who specializes in working with the unique needs of each patient and their
families. Our Social Workers / Navigators are responsible in performing distress screening
on all new cancer patients and providing intervention and referral as needed and as early as
possible. They are experienced mental health professionals with a wide range of expertise in
Psychotherapy, Crisis Intervention and Counseling. As Patient Navigators, they are
responsible in assessing potential barriers to access to care on all new cancer patients and
providing intervention to mitigate failure to comply with treatment and increase treatment
compliance based on identified potential and/ or actual barrier. Our Social Workers are also
available to provide education on advanced directives, disability, assistance with obtaining
needed oncology medications, logistical issues such as transportation and temporary
lodging, and can provide referrals for financial assistance.
Mount Sinai Comprehensive Cancer Center offers multiple support groups in both our Miami
Beach and Aventura locations facilitated by our Social Workers. As part of the Medical
Center we represent the Cancer Center on the Bioethics Committee and the Cancer
Committee. Our team members are active members of local, state and national
organizations and some hold positions of leadership within several local professional
organizations. We are partnered with community organizations such as the American
Cancer Society by hosting their Look Good Feel Better program and The Cancer Support
Community. The department organizes annual events such as Ladies’ Spa Day and
Survivors Day for the patients and their families.
Tuesday, October 15, 2013Program: 10:30 a.m. – 3:30 p.m.Registration begins at 10 a.m.
MUST RSVP. For information and to register, call 305.535.3407
Breakfast & Lunch Provided Free Parking Door PrizesBreakfast provided by: Levin Home Health and High Standards Health Services
Lunch provided by: Medivation, Incyte and Seattle Genetics
Mount Sinai Comprehensive Cancer Center 4306 Alton Road, Main Conference Center 2nd Floor
Spa DayPlease join us for a day of pampering and relaxation
Help support the Mount Sinai Comprehensive Cancer Center by purchasing a limited edition Key To The Cure T-shirt, designed by Pucci, and modeled by Jennifer Aniston, at Saks Fifth Avenue Bal Harbour.* 100% of the purchase price of each T-shirt will be donated to our cancer center to help fight women’s cancers. For more information on how you can participate in Key To The Cure, visit www.msmcfoundation.org/KeyToTheCure.
*Subject to availability
NAilS HAir MAKe-uP SKiN CAre Wig CAre MASSAge MediTATioN relAxATioN YogA gueST SPeAKerS
10TH ANNuAl lAdieS’
Screening Programs
The National Cancer Institute conducted a National Lung Screening Trial comparing two
ways of detecting lung cancer: low-dose helical computed tomography (CT) and standard
chest X-ray. Scientists found a 20% reduction in deaths from lung cancer among current or
former heavy smokers who were screened with CT versus those screened by chest X-ray.
The purpose of this program is to diagnose the disease in its earliest possible stage. Utilizing
low-dose Computerized-Tomography (CT), lung cancer screenings offers hope for survival
through early detection for high-risk patients. Mount Sinai Comprehensive Cancer Center
has established The Lung Cancer Screening Program, CTs for screening of patients is offered
at a reduced rate. The lung screening program has been featured in numerous printed ads
including: Pharmacy Choice, South Florida Sun Times, Sunny Isles Beach Sun, Miami Beach
News, PR Newswire and FHA News Clips.
During Lung Cancer Awareness month in November, the program offered free screening CTs
to patients who met the following screening criteria:
• Current smokers 55 to 74 years of age
• 30 pack-year history of cigarette smoking or higher (pack-year history = number
of cigarettes smoked per day x number of years smoked) and without a history of
lung cancer.
• Former smokers who have quit within the past 15 years
Patients who had a questionable result on their CTs were referred back to their referring
physician for further evaluation.
Lung Cancer Screening Program
Mount Sinai Medical Center 4300 Alton Road • Miami Beach, FL 33140
Mount Sinai Aventura 2845 Aventura Boulevard • Aventura, Florida 33180
305.535.3434 • msmc.com
Scan Me!Scan this QR code to learn more about the
Lung Center of Excellence at Mount Sinai Medical Center.
874
826
836
826
195
95
95
A1A
1
1
1
A1A
Miami Beach
North Miami
North MiamiBeach
hester
Kendall
Mount Sinai Aventura
Mount Sinai Medical Center
MS 8970 Lung Cancer Screening Program Brochure v2.indd 1 1/11/2013 12:20:06 PM
Early Diagnosis is Essential
When it comes to lung cancer – the leading cause of cancer death among men and women – tobacco users are among the most likely to develop the disease and the least likely to survive. Tobacco use accounts for 87 percent of lung cancer deaths in the United States, and smokers are up to 30 times more likely to develop lung cancer. But there is good news: When diagnosed early, more than 90 percent of lung cancers can be cured with prompt surgical intervention.
To learn more about Mount Sinai’s lung screening program,
or to schedule an appointment, please call 305.535.3434.
Low-dose CT Screenings Can Save LivesIn an effort to give at-risk patients a greater chance of survival, Mount Sinai Medical Center has developed a screening program aimed at diagnosing lung cancer at its earliest stage using low-dose computerized tomography (CT) scans. Because lung cancer typically doesn’t manifest signs and symptoms in its earliest stages, screenings increase the chance of diagnosing it early, when it can be more successfully treated.
What is a CT Scan? A CT scan is a painless, efficient exam. It combines a series of X-ray views taken from many different angles utilizing computer processing to create cross-sectional images of the bones and soft tissues inside your body. As a Radiation Safety Provider, Mount Sinai follows strict safeguards to ensure patients undergo diagnostic tests and screenings with the least amount of radiation exposure possible. Our radiologists are board certified, fellowship trained and sub-specialized, which helps provide the most accurate diagnosis possible.
Who Should Be Screened? Longtime tobacco smokers are among the most at-risk for lung cancer. Although others may also qualify, lung screenings are recommended for current and former smokers, ages 55 to 74, who have smoked one pack of cigarettes a day for 30 years and have no known history of lung cancer.
What Happens After the Screening? Your lung screening results are sent directly to your physician. If the screening reveals the need for further care, our patient navigator will contact you and guide you through any necessary next steps, such as additional testing, treatment and follow-up care. Our patients can rest assured that Mount Sinai Medical Center is a leader in comprehensive lung care. Our team of pulmonologists, thoracic surgeons and oncologists are highly trained and offer innovative interventions such as minimally invasive lung surgery, oncology treatments and superior quality lung and thoracic imaging that provide the best outcomes.
MS 8970 Lung Cancer Screening Program Brochure v2.indd 2 1/11/2013 12:20:06 PM
Outpatient Cancer Center Oncology Treatment
The outpatient center at Mount Sinai Comprehensive Cancer Center in Miami Beach
and Aventura cares for patients and delivers quality care to a wide variety of multiple cancer
diagnoses and blood disorders. The expertise of the nursing staff in delivering highly-
specialized cancer treatments is highlighted in a mixture of all staff nurses who are
chemotherapy and biotherapy certified, while others have obtained oncology nurse
certification from the national Oncology Nursing Society. The nursing team serves as the
patient advocate in facilitating a multidisciplinary approach to the patient’s care.
The treatment room at both Mount Sinai and Aventura is comprised of a centralized
nursing station, individual patient cubicles and private bedrooms, some of which offer a
spectacular view of downtown Miami and Biscayne Bay. The satellite center at Aventura is
strategically located in North Dade to provide services to a specific patient population. To
make patient’s treatment visits more enjoyable, cubicles and bedrooms are equipped with
televisions and DVD players.
The treatment room operates on a twelve hour a day schedule, Monday through
Friday, or until ‘the last patient leaves for the day’ to accommodate patients who need to
work during their treatments. Generally, patients receive their treatments on the same day
of their visit after seeing their physician. Individualized patient care is the goal of the
treatment room. All efforts are made to limit patients’ wait times, while ensuring
medications are administered to patients safely. Beepers are provided to patients so they
may freely roam the center and eventually receive a page once their medications are ready.
The treatment room at Miami Beach opens on weekends on a limited basis, to provide
continued care to patients who have started their treatment regimens during the week.
The treatment room at Miami Beach and Aventura serves as a vital component in
participation with research protocols and investigational trials. The nursing staff works
closely with research coordinators to participate in research regimens that will hopefully one
day make it to FDA approval for commercial use. The treatment room also serves as the
ground breaking arena for the initiation of new medication regimens, not currently offered
by other community and local cancer centers.
In essence, the treatment room shares in the vision of the Cancer Center in
delivering safe and comprehensive oncology care to the greater community that it serves,
and calling South Florida it’s home.
Cancer Data Center
The Cancer Data Center at Mount Sinai captures complete history, diagnosis, treatment, and
health status for every new cancer patient in the hospital system. This information is also
submitted to the National Cancer Data Base for comparison to other facilities in the US for
quality measures. Data for this report reflects cases first seen or diagnosed in 2012.
Total number of new cancer cases diagnosed and or treated during 2012 = 1,582
Our patients sometimes travel a long distance to be treated at Mount Sinai.
0 50 100 150 200 250 300
1
Most often treated cancers at MSMC - 2012
Leukemia Lymphoma Bladder Thyroid Colon
Kidney Melanoma Prostate Lung Breast
MIAMI-DADE
ST. LUCIE
OUT OF STATE
ALL OTHERS
BROWARD
MONROE
PALM BEACH
2012 County of Residence
Accountability Measures
Mount Sinai Medical Center participates in the Commission on Cancer’s - Cancer Program
Practice Profile Reports, otherwise known as CP R. This web based tool compares cancer
programs across the country and evaluates the treatment they offer their patients based on
certain criteria. This program currently reviews patients with Breast, Colon and Rectal
cancers and measures six treatment items from these cancers. Data submitted from the
hospital to the National Cancer Data Base is analyzed and returned to the hospital for
review.
The six review items are:
1. Radiation therapy is administered within one year (365 days) of diagnosis for women
under age 70 receiving breast conserving surgery (lumpectomy or partial
mastectomy) for breast cancer.
2. Combination chemotherapy is considered or administered within four months (120
days) of diagnosis for women under age 70 with a Stage T1cN0M0 or Stage II or III
hormone receptor negative breast cancer.
3. Tamoxifen or third generation aromatase inhibitor is considered or administered
within one year (365 days) of diagnosis for women with Stage T1cN0M0 or Stage II
or III hormone receptor positive breast cancer.
4. At least 12 regional lymph nodes are removed and pathologically examined for
resected colon cancer.
5. Post-surgical chemotherapy is considered or administered within four months (120
days) of diagnosis for patients under the age of 80 with Stage III (lymph node
positive) colon cancer.
6. Radiation therapy is considered or administered within six months (180 days) of
diagnosis for patients under the age of 80 with Stage T4N0M0 or Stage III and who
are receiving surgical resection for rectal cancer.
Any patient cases whose measure appears to fall below the established rates are reviewed.
Treatment updates are made to the database to ensure the most up to date information has
been gathered on each individual patient.
Mount Sinai Medical Center has consistently ranked in the highest performance rates for all
these measures since the program’s start date in January 2005.
Measure Estimated Performance Rates
2009 2010 2011
1. 92% 91% 91%
2. 100% 95% 86% *
3. 93% 91% 98%
4. 89% * 88% * 92%
5. 91% 74% * 77% *
6. 80% * 67% * N/A
Rates with an asterisk (*) have been calculated to still meet the confidence intervals set by the
Commission on Cancer to 90% and above.